A blood pump system intended for short-term management of cardiogenic shock (non-responsive to medical management) or severe cardio-respiratory insufficiency in adult and paediatric patients
NICE has now published a Medtech Innovation Briefing on the Levitronix centrimag.
 
Status Discontinued
Decision Selected
Process MTG
Referral date 01 February 2010
Topic area
  • Cardiovascular
  • Surgical procedures
  • Therapeutic procedures

Project Team

Project lead N/A

Stakeholders

  • NICE is developing guidance on this technology. If you would like to become a registered stakeholder in the development of guidance on this technology, please complete a stakeholder registration and confidentiality form (Word), and return to us at medtech@nice.org.uk.

    Registered stakeholders will be informed of key stages in the development of guidance including when documents go out to consultation or comment.

For further information on our processes and methods, please see our CHTE processes and methods manual